VanEck Associates
ARTX

VanEck Associates’s Arotech Corporation ARTX Stock Holding History

VanEck Associates’s Portfolio ARTX Stock Details ARTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,272
Closed -$24K – 1026
2019
Q3 		$24K Buy
8,272
+28
+0.3% +$62 ﹤0.01% 815
2019
Q2 		$16K Sell
8,244
-5,222
-39% -$13.1K ﹤0.01% 816
2019
Q1 		$39K Buy
13,466
+313
+2% +$999 ﹤0.01% 796
2018
Q4 		$34K Buy
13,153
+4,352
+49% +$12.2K ﹤0.01% 774
2018
Q3 		$30K Buy
8,801
+504
+6% +$1.81K ﹤0.01% 775
2018
Q2 		$31K Buy
8,297
+2,660
+47% +$9.46K ﹤0.01% 827
2018
Q1 		$17K Buy
5,637
+376
+7% +$1.28K ﹤0.01% 723
2017
Q4 		$19K Sell
5,261
-3,891
-43% -$15K ﹤0.01% 714
2017
Q3 		$38K Buy
9,152
+409
+5% +$1.48K ﹤0.01% 719
2017
Q2 		$31K Buy
+8,743
New +$28.8K ﹤0.01% 729

VanEck Associates's ARTX Position: Q4 2019 in Review

VanEck Associates sold out of Arotech Corporation (ARTX) in Q4 2019, closing a stake of 8,272 shares — an estimated $24K sold.

VanEck Associates first reported a position in ARTX in Q2 2017 and held it in 10 quarters. The position peaked at $39K in Q1 2019. 0 funds tracked by Wall St. Rank hold ARTX as of Q4 2019.

  • VanEck Associates reported no remaining Arotech Corporation position as of Q4 2019 after selling out during the quarter.
  • VanEck Associates sold 8,272 Arotech Corporation shares in Q4 2019, an estimated $24K.
  • VanEck Associates first reported a position in Arotech Corporation in Q2 2017 and held it in 10 quarters.
  • VanEck Associates's Arotech Corporation position peaked at $39K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Arotech Corporation as of Q4 2019.

Based on VanEck Associates's 13F filing for Q4 2019, filed 13 Feb 2020.